Aleafia Health Inc. Aphria Inc. Aurora Cannabis Inc. cannabis cannabis companies Canopy Growth Corp. CBD extraction CBD industry Cronos Group Inc. Elixxer Ltd. Green Organic Dutchman Holdings ICC International Cannabis Corp. Investing marijuana marijuana sales in Europe Organigram Holdings Inc. POT pot stocks StillCanna Inc. Stocks & ETFunds Tech Tilray Inc.

Central Cannabis: These companies intend to become major players in Europe

Central Cannabis: These companies intend to become major players in Europe

by Lorimer Wilson (

The CBD sector is projected to grow by greater than 400% by 2023 in Europe (source), making it the most important the authorized cannabis market on the planet. This can be a nice opportunity for corporations to penetrate and / or develop throughout Europe with a lot much less competitors than we see in the US and Canada.

Why give attention to Europe? Provided that the CBD represents a large and underdeveloped emerging market, estimated at C $ 66.8 billion by 2020, and that European governments have adopted CBD early, the product is readily available over-the-counter, stored in local outlets. pharmacies and out there on-line.

The businesses described under might properly turn out to be the primary suppliers of this booming market.

1. StillCanna Inc. (CSE: STIL, OTCPK: SCNNF), a Canadian improvement life sciences firm specializing within the large-scale extraction of CBD in Europe, seized this opportunity by combining its Exclusive strengths within the extraction and distillation of pure CBD from hemp and / or hashish oils have been the topic of numerous key acquisitions and initiatives, as follows:

  • acquired in March Olimax, a Polish farmer, extractor and formulator of vertically built-in hemp, making StillCanna one of many largest hemp growers in
  • throughout Europe signed an unique extraction contract with the supplier CBD, Dragonfly BioSciences LLC, which is predicted to generate $ 46 million in revenue over the subsequent three years.
  • developed its personal registered hemp seeds with a brief gestation period permitting the company to plant two crops a yr from 2020,
  • are house owners of several agricultural-based patents that give the corporate
  • created a brand new extraction facility in Poland, referred to as Nexus, which shall be absolutely operational in the fourth quarter,
  • and building another CBD extraction facility in Poland, referred to as Horizon, which ought to be operational in 10
  • some of the advanced, ecological and high-capacity amenities on the earth over 14 months, has handed the ultimate levels of the licensing strategy of its ORIGIN extraction facility in Romania, a three way partnership with its UK-based companion Dragonfly Biosciences plans to finalize the license and complete manufacturing by the 4th quarter of 2019 and
  • s & # Expects to develop 12,500 acres and produce as much as 60 million grams by 2021, with plenty of progress margin beyond that.
  • Founder Marc Crimeni moved to Europe at the finish of July to give attention to CBD bulk gross sales.
  • The administration of particular person insiders held 3% of the inventory.
  • The corporate modified its identify to S tillCanna Inc. of EVI International Group Developments Corp. in March 2019.

For an in depth financial analysis, please click on here. You will not be disillusioned.

Despite the acquisitions and initiatives of StillCanna Inc., as noted above, its worth is down 55% from its current peak of April 18th.

2. ICC International Cannabis Corp. (CSE: WRLD.U), a Canadian firm specializing in the acquisition and operation of hashish belongings worldwide, with a give attention to Europe, is on the best way to turning into the world's first pure publicly traded pure hashish play. It also builds and operates high-quality, low-cost hashish production, processing and distribution amenities all over the world.

The corporate:

  • has obtained the unique European license of the Affinity Alpha Unit, whose extraction know-how will permit the company to increase the anticipated yield by 40% to 50% and restrict losses of cannabinoids associated to the prevailing extraction course of, which can scale back prices and help the company to improve its margins,
  • made a strategic investment in Biotii Applied sciences Corp., a personal firm based mostly in Boston company, which needs to place in place processes for the mass manufacturing of genetically modified micro-organisms expressing CBD / THC profiles equivalent to these present in nature at a fraction of the price of present cannabis manufacturing strategies and with a extra constant production quality ,
  • has signed a licensing settlement with Genuine Brands Group for the advertising and distribution of health and wellness merchandise. be derivatives of cannabidiol all through & # 39; Europe
  • acquired a strategic investment of $ 5 million in the form of a convertible debenture Auxley Cannabis Group Inc. (TSXV: XLY) successfully. broadening its international footprint in 22 nations on 5 continents,
  • plans to introduce VendaPharm, MarinaBox and Bamboo merchandising machines in high-traffic shops and pharmacies by way of its European network downstream of 80,000 points of sale , pharmacies and stores wide selection of branded THC / CBD products,
  • acquired 49.9% of Wayland Group Corp. (CSE: WAYL), a vertically built-in cannabis grower and processor with production amenities in Canada, Germany, Switzerland and Italy, in addition to belongings in Colombia and Argentina and
  • Swiss Culture Amenities 60,000 square ft of ICC have positioned the company at the epicenter, each economically and economically. geographically, a booming market to satisfy the rising demand for CBD on the continent.

For an in depth monetary evaluation, please click on right here. You’ll not be disenchanted.

Regardless of ICC efforts thus far, plans for the longer term share worth of the ICC have fallen by 88% within the last seven months.

3. Aleafia Well being Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) is a vertically built-in hashish well being and wellness firm with three hashish crops in Ontario, Canada, the place it produces diversified portfolio of products including oils, capsules and sprays. The corporate additionally operates a national network of 22 medical cannabis clinics.

Final Might, she entered the German medical cannabis market with a 50/50 three way partnership, by means of her wholly-owned subsidiary Emblem Hashish Corp. pharmaceutical wholesaler Acnos Pharma Gmbh. The JV entity will buy Aleafia Health brand hashish oils for distribution in German pharmacies and to be used in medical trials. Because:

  • in line with a report by the Financial institution of Montreal, the German market for medical cannabis is predicted to generate $ 5 billion in revenues by 2025 for cannabis producers, and Aleafia needs to immediately take part on this progress and the German market
    • has considerably larger margins than the Canadian market and
    • affected person buy prices are reimbursed by way of personal and public medical insurance.

Why Acnos? Because he:

  • has entry to 110 distribution centers and 20,000 pharmacies, in addition to to many distribution channels in Europe, and
  • is at present building a middle dedicated to the storage and the execution of cannabis orders in his new headquarters.

The Aleafia stock jumped 24% with the announcement of the Acnos J / V in Might, but continued its decline and is now down 63% from the peak of February 5th 2019.

For an in depth financial evaluation, please click right here.

4. Elixxer Ltd. (TSXV: ELXR), a Canadian funding holding firm specializing within the acquisition of production, manufacturers and distributors in established and creating cannabis markets, focuses on international markets, which can assist them derive profit from rising worldwide demand for hashish

The company:

  • on August 6, 2019, was renamed LGC Capital Ltd. Elixxer Ltd.,
  • signed a letter of intent in March 2018 with the Italian firm Evolution BNK, a 70,000 sq. foot cannabis producer in Sanremo, Italy, acquires a 49% interest at a later date beneath certain circumstances and provides an choice to buy a 5% royalty on internet sales,
  • concluded an investment agreement in Might 2019, acquisition of a 35% stake in Freia Farmaceutici Srl, the only Italian firm – and one of many few in Europe – to have developed and marketed hemp-based pharmaceutical merchandise licensed by European Meals The Authority and
  • sell their cannabis products in more than 1,000 retailers in Switzerland and Italy.


For an in depth financial analysis, go right here.

ELXR is ready for the acquisition of Freia. present vital synergies for the company in Europe but, up to now, this benefit has not translated into greater share prices. It's nonetheless a penny stock within the true sense of the word buying and selling at $ 0.08 and down 38% from the height reached on April 4th.

Along with the aforementioned very small capitalization corporations, the following corporations are much larger and a lot better established:

5. Inexperienced Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) focuses on the medical hashish markets in Canada, Europe, the Caribbean and Latin America, in addition to the Canadian adult market. It additionally operates CBD oils created from organic hemp in Canada and the EU by way of its wholly owned subsidiary, HemPoland.

The company:

  • introduced its enlargement into the hemp CBD market in June with the launch of its International Strategic Hemp. Division that may help the worldwide companions of the society by:
    • providing schooling in genetics,
    • on organic methods and commonplace operating procedures and
    • on regulation and different advisory providers,
  • signed a letter of intent with Queen Genetics / Knud Jepsen A / S, based mostly in Hinnerup, Denmark, as part of a 50:50 joint venture :
    • provide a continuing supply of organic quality hashish, grown in Europe,
    • grant TGOD the exclusive rights to all hashish manufacturing of the JV and
    • convey the funded capacity of TGOD to 195 000 kg ,
  • acquired HemPoland in 2018, facilitating its entry into the German CBD market and, to this finish,
    • signed a distribution settlement with Mediakos, a number one German pharmaceutical distributor and
  • had in depth discussions with further packagers and distributors to further broaden its footprint in Europe.

Like most different pan shares, TGOD's stock worth stays comparatively low, down 42% from its March document.

For a detailed financial analysis, go here.

6. OrganiGram Holdings Inc. (TSX-V: OGI) (NASDAQ: OGI) is nicely positioned in Europe and makes the following investments:

  • In June 2018, OGI invested US $ 10,000,000 within the hemp and CBD Eviana Well being Company, based mostly in Serbia, situated at) For 26% of its shares outstanding on an undiluted foundation (and 40% on a totally diluted basis), present Organigram with a supply of low value and top quality CBD for the booming medical market in Europe.
  • In October 2018, alpha-cannabis Pharma GmbH (ACG), a German company, acquires a 25% stake in Stadthagen, strategically positioned to serve more than 20,000 pharmacies in Germany, Austria and Switzerland.

The inventory of OrganiGram is down 46% since its peak on Might 17th

For an in depth monetary evaluation, go right here.

7. Tilray Inc. (NASDAQ: TLRY) is making a valiant effort to determine itself as described under:

  • On July 23, Tilray introduced the acquisition of the British firm Smith & Sinclair, developer / producer / sweet sweet dispenser. , edible fragrances and other distinctive cocktail treats. The settlement provides Tilray a solution to develop new cannabis-based products because it tries to distinguish itself and appeal to new clients. It also needs to give a serious increase to the company's efforts to enter the CBD-impregnated food market simply in time for the legalization of those merchandise. shopper products in Canada on the end of 2019.
  • This week, Tilray Portugal's subsidiary, Tilray Portugal Unipessoal Lda., has signed an settlement with Canicheical Pharma GmbH for the export of 3.3 tens of millions of dollars of medical hashish in Germany. a a lot larger market than that of his residence nation, Canada.

Tilray needs a shot in the arm contemplating the performance of her inventory that has been terrible this yr. At the close of business on August 26, Tilray shares have been down 72% from the height of February 28th.

For a detailed financial analysis, please click on right here

8. Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) continues to strengthen its position within the European medical cannabis market to be able to enter new markets as regulatory obstacles crumble. and that demand is growing.

Aurora has a manufacturing capacity larger than that of another firm with an annual manufacturing of more than 500,000 kg and, as production will increase throughout Canada, provide might exceed demand by 2021 and, as a way to promote its extra national supply, Aurora expands on the European markets Aurora

  • then created a European subsidiary, Aurora Europe GmbH, to manage its business in Europe, with divisions in Germany (Aurora Deutschland GmbH ), in Poland (Aurora Polska) and in the Netherlands (Aurora Nederland BV),
  • entered in January 2018 with Alfred Pedersen & Son for a 51% stake in Aurora Nordic Cannabis A / S, the joint venture. The corporate is predicated in Odense, Denmark and is among the few corporations to have a license to develop in Europe, making it the most important hashish producer on the continent.
    • Aurora Nordic will concentrate on the cultivation and sale of hashish in Denmark, Sweden, Norway, Finland and Iceland, by way of its wholly-owned subsidiary Pedanios GmbH (a serious importer, exporter) and distributor of cannabis for medical purposes in the European Union), based mostly in Germany) with excess capacity distributed in other EU nations with the help of Pedanios
    • Based on Terry Booth, CEO of Aurora, the three way partnership has established Aurora as a cannabis firm in Europe and the main exporter and distributor of medical cannabis in Germany.
  • obtained the proper, via the middleman of its subsidiary Aurora Deutschland, to provide Italy (the second largest market for medical cannabis in Europe) with a complete of 400 kilograms of medical marijuana throughout over the subsequent two years, [19659007] acquired 51% of Gaia Pharm in Portugal, which will probably be renamed Aurora Portugal, following the EU's approval of the construction of a hashish growing middle to be accomplished (first part) within the third quarter of 2020,
  • accomplished its first business export of hashish oil to the United Kingdom,
  • began development of an indoor hashish production website in Leuna, Germany, in Might 2019, inside 12 months and the primary deliveries of hashish grown regionally. to be obtainable for German medical patients as of October 2020.

For an in depth financial evaluation, please click on here

At the close of enterprise on August 26, the stock of Aurora is down 42 % from the peak on March 18, 2019.

9. Canopy Progress Corporation (TSX: WEED) (NYSE: CGC), one of many largest medical cannabis corporations on the planet, is investing closely in Europe to increase manufacturing over the subsequent two years via new rising amenities in Italy, Greece or Spain. Extra particularly, Canopy, via its subsidiary Spectrum Hashish, has:

  • acquired the licensed cannabis producer based mostly in Spain, Cáñamo y Fibras Naturales, SL, completing the company's present manufacturing website in Denmark ( Spectrum Hashish Denmark), in addition to its German manufacturing unit Storz and Bickel, licensed ISO 13485 (Spektrum Hashish Germany).
  • is associated with Alcaliber SA to grow marijuana and extract its oil
  • has bought C3 Cannabinoid Compound, a German company specializing in medical remedies based mostly on cannabinoids used by European docs,
  • bought the British group of skin care and well-being This Works last Might and
  • purchased Annabis Medical which can function beneath the identify of Spectrum Cannabis Czech.

For a detailed monetary evaluation, go here

At the shut of enterprise on August 26, the Cover inventory was down 52% from its peak on April 29, 2019.

10 . Cronos Group Inc. (NASDAQ: CRON, TSX: CRON) is involved within the manufacturing and sale of cannabis in Canada, Poland and Germany.

Cronos states:

  • an exclusive five-year distribution settlement with G. Pohl-Boskamp. in Germany, permitting it to distribute its product in more than 12,000 pharmacies within the nation and
  • underneath a five-year unique distribution agreement with Delfarma Sp. Zo.o permitting it to distribute its products in more than 5,000 pharmacies and more than 200 hospitals representing about 40% of the Polish domestic market.

For an in depth monetary evaluation, please click on right here.

From the close of business to the close of business. On August 26, the Cronos stock is down 52% from its peak on March 5, 2019.

11. Aphria Inc. (TSX: APHA; NYSE: APHA) is likely one of the lowest value medical hashish producers in Canada.


  • gained a fifth lot (maximum allowed) for cultivation for medical functions. cannabis in Germany – it is the only approved producer in Germany to be allowed to cultivate the three medical hashish strains authorised by the German Federal Institute for Medicine and Medical Units – claiming its leading position on the German medical hashish market.
  • Indoor growing facility of 8, 000 sq. meters in Neumünster and will have the ability to provide the first medical cannabis cultivated in the nation in Germany at first of the yr 2020,
  • completes the work of 39, a top quality hashish storage middle, GMP licensed, in Dangerous Bramstedt, Germany, for the import of flowers and hashish oil,
  • has entered right into a 15% strategic partnership (with the potential for improve the ownership to 50% beneath sure circumstances) with De Schroll Medical (subsidiary of a serious European flower producer), based mostly in nmark, aims to continue the cultivation and worldwide distribution of natural medical hashish, licensed GMP by the EU. To this finish, Aphria has simply accomplished its first transfer of plant cuttings to Schroll.
  • holds a 25.1% stake in Berlin's Schöneberg Hospital, which allows him to consult both docs and sufferers to study more about the advantages of cannabinoids for medical purposes [19659007] has launched to the German market a line of CBD-based nutraceuticals and cosmetics, produced in the EU and distributed by CC Pharma, a subsidiary of Aphria with access to more than 13,000 pharmacies all through the world. Germany, which she acquired in January yr
  • acquired the primary medical hashish import license from the Malta Medicines Authority, which can permit her Malta-based subsidiary ASG Pharma, a big laboratory licensed by the EU, to develop into a cornerstone of testing, research and improvement on medical hashish in Europe.

For an in depth financial evaluation, please click on here.

At the shut of business on August 26, Aphria shares are down 44%. February 5, 2019.


Potato shares getting into the European market are presently performing worse than the market as an entire, however this should change given their early positioning on the booming European market. .

Want extra gadgets like this? "Comply with the munKNEE" on Fb, Twitter or our FREE fortnightly publication on the Market Intelligence Report (see example here, register within the higher proper nook of the web page).
within the Remark part on the bottom of the page.
Needed articles: unique articles and links to other informative articles deserving wider reading. Send info to loriewil [at] yahoo [dot] com.

window .___ gcfg = lang: in-US & # 39;
(perform (w, d, s)
go () perform
var js, fjs = d.getElementsByTagName (s) [0] load = perform (url, id)
if (d.getElementById (id)) return;
js = d.createElement (s); js.src = url; = id;
fjs.parentNode.insertBefore (js, fjs);
load (// join.fb.internet/en/all.js#xfbml=1&#39 ;, & # 39; fbjssdk & # 39;);
load (https: // ;, & # 39; gplus1js & # 39;);
load (// ;, & # 39; tweetjs & # 39;);

if (w.addEventListener) w.addEventListener ("load", go, false);
else if (w.attachEvent) w.attachEvent ("onload", go);
(window, doc, & quot; script & quot;)

window .___ gcfg = lang: in-US & # 39;
(perform (w, d, s)
go () perform
var js, fjs = d.getElementsByTagName (s) [0] load = perform (url, id)
if (d.getElementById (id)) return;
js = d.createElement (s); js.src = url; = id;
fjs.parentNode.insertBefore (js, fjs);
load (// join.fb.internet/en/all.js#xfbml=1&#39 ;, & # 39; fbjssdk & # 39;);
load (https: // ;, & # 39; gplus1js & # 39;);
load (// ;, & # 39; tweetjs & # 39;);

if (w.addEventListener) w.addEventListener ("load", go, false);
else if (w.attachEvent) w.attachEvent ("onload", go);
(window, doc, & quot; script & quot;)